Patent · US Active

Compounds and methods of use

US11077101B1 · kind B1 · utility

5Cited by
2References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 18, 2019
Grant dateAug 3, 2021
Priority date
Expiry dateJul 18, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X1, X2, X3, X4, Y, A, L1, L2, R1, R2, R5, m and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.